Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CS-206
GENETIC
2 trials
Sponsors
CorrectSequence Therapeutics Co., Ltd
, Children's Hospital of Fudan University
Conditions
Sickle Cell Disease
Early Phase 1
CS-206 in Patients With Sickle Cell Disease
Recruiting
NCT06565026
CorrectSequence Therapeutics Co., Ltd
Sickle Cell Disease
Start: 2024-09-02
End: 2027-06-30
Target: 5
Updated: 2026-02-10
CS-206 in Patients With Sickle Cell Disease
Not yet recruiting
NCT07000318
Children's Hospital of Fudan University
Sickle Cell Disease
Start: 2026-09-30
End: 2029-03-31
Target: 5
Updated: 2026-05-15
Related Papers
Clinical base editing for β-hemoglobinopathies across different genetic backgrounds.
2026-09-07